Literature DB >> 16483094

Children's perspectives of a pediatric hospice program.

Betty Davies1, John B Collins, Rose Steele, Karen Cook, Amy Brenner, Stephany Smith.   

Abstract

Little attention has been paid to documenting the experiences of children in pediatric palliative care programs, both those who are ill and their siblings. In this evaluation study of Canuck Place, a Canadian, free-standing hospice program, 26 ill children and 41 of their siblings completed mail-out questionnaires. In addition, four ill children and 10 siblings participated in face-to-face interviews. Results indicate that nearly all children were enthusiastic about the program's activities and the physical environment at Canuck Place. Engaging activities, physical amenities, and the social climate promoted by staff, volunteers, and other families were important contributors to the children's satisfaction. Suggestions for better serving adolescents included: a wider range of age-appropriate activities, games, and toys--especially for teens and older children; more trips and tours outside the building and around town; and caring staff and volunteers who are "attentive-in-the-moment". From the children's perspective, the key to Canuck Place's success is its social climate of caring, safety, friendliness, acceptance, and variety.

Entities:  

Mesh:

Year:  2005        PMID: 16483094

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  3 in total

1.  End-of-life management in pediatric cancer.

Authors:  Claudia L Epelman
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

2.  A place to die: The case for paediatric inpatient hospices.

Authors:  Adam Rapoport
Journal:  Paediatr Child Health       Date:  2008-05       Impact factor: 2.253

3.  Pediatric Palliative Care: A Five-Year Retrospective Chart Review Study.

Authors:  Susan E Thrane; Scott H Maurer; Susan M Cohen; Carol May; Susan M Sereika
Journal:  J Palliat Med       Date:  2017-06-06       Impact factor: 2.947

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.